… be doing better with other treatments.” REFERENCE 1. Xu W, Choueiri … with clinical outcomes in advanced renal cell carcinoma (aRCC): Retrospective analysis of COSMIC …

This discussion reviews the pivotal trials that have established current frontline standards. Studies evaluating immunotherapy and targeted therapy combinations consistently demonstrate significant improvements in overall survival, response rates, and …

… locally advanced RCC. Recent trials have demonstrated that systemic treatment in this … likely to benefit from systemic treatment are identified early. The discussion … recurrence risk is moderate or treatment tolerance is uncertain. Panelists conclude …

… intricate mechanisms underpinning renal cell carcinoma (RCC). Their findings propose … potential of developing drugs aimed at this … renal cell carcinoma underscores a promising horizon for cancer research and treatment … pathway. J Transl Med 23, 1207 (2025 …

… of its existing kidney cancer treatment, Fotivda (tivozanib), marketed in the … and provide new treatment options for patients with renal cell carcinoma. The U.S … . kidney cancer treatment market is …

Treating advanced non-clear cell renal cell carcinoma (nccRCC) poses challenges … drug-drug interactions and polypharmacy with patients managing lots of pills. … issues with these TKI drugs? Baddi: It is … you treat with these treatment paradigms we just talked …

… therapy. Drug therapy is the main treatment method, where the main drugs for … were analyzed as potential concomitant medications. The analytical technique used for … Metastatic Renal Cell Carcinoma: a Retrospective Analysis of Real-World Data. Clin Med Insights …

… with advanced clear-cell renal cell carcinoma (RCC).2  Of the 20 … ports and syringes during drug dilution. Of these … limited to, receiving prior treatment with an investigational anti … With Advanced Clear Cell Renal Cell Carcinoma. ClinicalTrials.gov. Updated …

… challenge in metastatic clear cell renal cell carcinoma (ccRCC) management: although multiple … Haake began. He explained that treatment decisions in ccRCC are largely … Building upon these observations, OPTIC RCC prospectively applied RNA sequencing to …

… imaging. Eur J Nucl Med Mol Imaging. 2022;49 … the clinic. Bioeng Transl Med. 2024;9(1):e10600. … biology of anti-drug antibody formation following treatment with monoclonal antibodies … aptamer) in metastatic renal cell carcinoma. Invest New Drugs. 2014;32(1): …